Iridex (IRIX) Return on Invested Capital (2021 - 2022)

Iridex (IRIX) posted quarterly Return on Invested Capital of 0.02% for Q1 2022, down 38.96% quarter-over-quarter from 0.02% in Q4 2021.

Iridex (IRIX) Return on Invested Capital (2021 - 2022) Analysis & Trends

Iridex's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.02% for Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	0.01%
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	0.01%
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	0.01%
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	-
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	0.01%
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	0.00%
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	0.04%
10	Iridex	13.09 Mn	8.41 Mn	4.30 Mn	-

Download Data